Full Text View
Tabular View
No Study Results Posted
Related Studies
Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mg
This study has been completed.
Study NCT00650195   Information provided by Mylan Pharmaceuticals
First Received: March 30, 2008   Last Updated: March 31, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Interventions listed in this trial
Metolazone Tablets 10 mg
Zaroloxyn® Tablets 10 mg
Additional drug interventions recognized in this trial
Metolazone
More general drug interventions related to this trial
Antihypertensive Agents
Cardiovascular Agents
Diuretics
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Mylan Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services